APM
BPMC
Avidity Partners Management’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-68,500
| Closed | -$6.06M | – | 60 |
|
|
2025
Q1 | $6.06M | Sell |
68,500
-108,100
| -61% | -$9.57M | 1.16% | 33 |
|
|
2024
Q4 | $15.4M | Sell |
176,600
-138,400
| -44% | -$12.1M | 1.51% | 28 |
|
|
2024
Q3 | $29.1M | Sell |
315,000
-68,000
| -18% | -$6.29M | 1.49% | 27 |
|
|
2024
Q2 | $41.3M | Sell |
383,000
-43,000
| -10% | -$4.63M | 1.75% | 19 |
|
|
2024
Q1 | $40.4M | Sell |
426,000
-189,000
| -31% | -$17.9M | 1.3% | 27 |
|
|
2023
Q4 | $56.7M | Sell |
615,000
-136,600
| -18% | -$12.6M | 2.07% | 15 |
|
|
2023
Q3 | $37.7M | Buy |
751,600
+336,600
| +81% | +$16.9M | 1.52% | 30 |
|
|
2023
Q2 | $26.2M | Buy |
+415,000
| New | +$26.2M | 0.92% | 46 |
|
|
2022
Q2 | – | Sell |
-291,184
| Closed | -$18.6M | – | 87 |
|
|
2022
Q1 | $18.6M | Sell |
291,184
-703,816
| -71% | -$45M | 0.39% | 54 |
|
|
2021
Q4 | $107M | Buy |
995,000
+163,000
| +20% | +$17.5M | 2.26% | 16 |
|
|
2021
Q3 | $85.5M | Buy |
832,000
+268,800
| +48% | +$27.6M | 1.9% | 12 |
|
|
2021
Q2 | $49.5M | Buy |
563,200
+17,200
| +3% | +$1.51M | 1.34% | 27 |
|
|
2021
Q1 | $53.1M | Buy |
546,000
+306,000
| +128% | +$29.8M | 1.47% | 24 |
|
|
2020
Q4 | $26.9M | Buy |
+240,000
| New | +$26.9M | 0.87% | 41 |
|